… Easily distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID…
efficacy of molnupiravir in the treatment of COVID-19 ( ClinicalTrials.gov NCT04405570 ). …

… trial to evaluate the efficacy and safety of treatment with molnupiravir started within 5 days
after the … Participants in the trial were randomly assigned to receive 800 mg of molnupiravir or …

Background Safe and effective oral treatments are needed to improve clinical outcomes for
nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small-…

… , molnupiravir treatment completely blocked transmission of virus to untreated animals,
suggesting that early treatment … This study was initiated as a single-center, single-dose study, …

… of the molnupiravir administration in the treatment of patients … of molnupiravir on the
appearance of drug resistance-related mutations. Therefore, molnupiravir can be effective in treating …

… that early intervention with molnupiravir resulted in a greater … explained the failure of
molnupiravir in hospitalized patients … regimens for the treatment of viral diseases. This contrasts …

… -19 were randomized and treated with molnupiravir (n = 710) … reactions in the molnupiravir
treatment group were diarrhea (2… authorization for molnupiravir 200 mg capsules, Center for …

… We conducted additional analyses to evaluate additional potential benefits of molnupiravir
for the treatment of mild to moderate COVID-19 based on clinical markers and the need for …

… molnupiravir in patients hospitalized with Covid-19. … received at least one dose of molnupiravir
and 75 of placebo. At … (55.5%) molnupiravir-treated and 46 of 75 (61.3%) placebo-treated …

… Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to moderate
cases of coronavirus disease … of adult patients treated with molnupiravir in an outpatient …